Skip to main content
Journal cover image

1079 Phospho-proteomic profiling reveals distinct signaling pathways by first and third generation EGFR inhibitors in human keratinocytes: Implications for adverse dermatologic reactions

Publication ,  Conference
Vasavda, C; Kwatra, MM; Kwatra, SG
Published in: Journal of Investigative Dermatology
May 2018

Duke Scholars

Published In

Journal of Investigative Dermatology

DOI

ISSN

0022-202X

Publication Date

May 2018

Volume

138

Issue

5

Start / End Page

S183 / S183

Publisher

Elsevier BV

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vasavda, C., Kwatra, M. M., & Kwatra, S. G. (2018). 1079 Phospho-proteomic profiling reveals distinct signaling pathways by first and third generation EGFR inhibitors in human keratinocytes: Implications for adverse dermatologic reactions. In Journal of Investigative Dermatology (Vol. 138, pp. S183–S183). Elsevier BV. https://doi.org/10.1016/j.jid.2018.03.1092
Vasavda, C., M. M. Kwatra, and S. G. Kwatra. “1079 Phospho-proteomic profiling reveals distinct signaling pathways by first and third generation EGFR inhibitors in human keratinocytes: Implications for adverse dermatologic reactions.” In Journal of Investigative Dermatology, 138:S183–S183. Elsevier BV, 2018. https://doi.org/10.1016/j.jid.2018.03.1092.
Vasavda, C., et al. “1079 Phospho-proteomic profiling reveals distinct signaling pathways by first and third generation EGFR inhibitors in human keratinocytes: Implications for adverse dermatologic reactions.” Journal of Investigative Dermatology, vol. 138, no. 5, Elsevier BV, 2018, pp. S183–S183. Crossref, doi:10.1016/j.jid.2018.03.1092.
Journal cover image

Published In

Journal of Investigative Dermatology

DOI

ISSN

0022-202X

Publication Date

May 2018

Volume

138

Issue

5

Start / End Page

S183 / S183

Publisher

Elsevier BV

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences